
RedHill Biopharma Investor Relations Material
Latest events

Q1 2022
RedHill Biopharma

H2 23/24
9 Apr, 2025

Corporate Presentation
15 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from RedHill Biopharma Ltd
Access all reports
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company focused on the development and commercialization of treatments for gastrointestinal and infectious diseases. The company markets a portfolio of approved products in the United States and is also engaged in clinical development programs targeting conditions such as Crohn’s disease, Helicobacter pylori infection, and COVID-19. RedHill conducts research and commercial activities both independently and through strategic partnerships. The company is headquartered in Tel Aviv, Israel, and its shares are listed on the NASDAQ.
Key slides for RedHill Biopharma Ltd


Corporate Presentation
RedHill Biopharma Ltd


Corporate Presentation
RedHill Biopharma Ltd
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
RDHL
Country
🇺🇸 United States